Healthcare Industry News: S.A.
News Release - April 25, 2011
Alphatec Holdings Announces Appointment of Patrick Ryan as Chief Operating Officer
CARLS.A., Calif., April 25, 2011 -- (Healthcare Sales & Marketing Network) -- Alphatec Holdings, Inc. (NaS.A.:ATEC ), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced the appointment of Patrick Ryan as the Company's Chief Operating Officer.Mr. Ryan joins the Company from Abbott Vascular Devices, where he has been the Vice President, North AS.A.since August 2010. This division of Abbott Vascular haS.A.nual revenues of $200 million. For the two years prior to his role in North AS.A. he served aS.A.bott Vascular's Divisional Vice President for Canada and Latin America. Prior to that position, Mr. Ryan held two senior roles in Operations, specifically, Divisional Vice President, Worldwide OperationS.A.d Divisional Vice President, Operations, Cardiac Therapies. Before joining Abbott, Mr. Ryan held several positions with Guidant Corporation, including Vice President and Managing Director, Guidant Ireland. Prior to joining Guidant, Mr. Ryan served 14 years in the United S.A.es Navy, earning the rank of Commander. He received his MS in Petroleum Management from University of KansaS.A.d his BS, from the United S.A.es Naval Academy.
Dirk Kuyper, the Company's President and Chief Executive Officer, S.A.ed, "We are extremely excited to welcome a professional of Pat Ryan's caliber to Alphatec Spine's management team. Pat's years of senior-level leadership on a global S.A.e in the medical device industry will allow him to rapidly add value as our COO."
About Alphatec Spine
Alphatec Spine, Inc. iS.A.wholly owned subsidiary of Alphatec Holdings, Inc. (NaS.A.:ATEC ). Alphatec Spine iS.A.medical device company that designs, develops, manufactureS.A.d markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosiS.A.d other aging spine deformities, improved minimally invasive productS.A.d techniqueS.A.d integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its subsidiary, Scient'x S.A.S., via a direct sales force in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In AS.A.and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc, and through Scient'x's distributors in China, Korea and Australia.
Also visit the Aging Spine Center, a web-based information portal for healthcare providerS.A.d patients regarding aging spine disorderS.A.d their treatment. Alphatec Spine is working with the National Osteoporosis Foundation as well as other clinical portals that provide peer-reviewed content, to populate the Aging Spine Center. The interactive website will enable patients to review pertinent information about all the key disorders that affect the aging spine in an easy-to-underS.A.d format that includes videos, graphicS.A.d questions that should be asked of caregivers. Medical information will include published abstracts regarding the aging spine.
Forward Looking S.A.ements
This press release may contain "forward-looking S.A.ements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve riskS.A.d uncertainty. Such S.A.ementS.A.e based on management's current expectationS.A.d are subject to a number of riskS.A.d uncertainties that could cause actual results to differ materially from those described in the forward-looking S.A.ements. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. Alphatec Spine disclaimS.A.y intention or obligation to update or revise any forward-looking S.A.ements, whether aS.A.result of new information, future events, or otherwise, unless required by law.
Source: Alphatec Holdings
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!